- Home
- RNA vs GNW Comparison
RNA vs GNW Comparison
Compare RNA & GNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNA
- GNW
- Stock Information
- Founded
- RNA 2012
- GNW 1871
- Country
- RNA United States
- GNW United States
- Employees
- RNA N/A
- GNW N/A
- Industry
- RNA Biotechnology: Pharmaceutical Preparations
- GNW Life Insurance
- Sector
- RNA Health Care
- GNW Finance
- Exchange
- RNA Nasdaq
- GNW Nasdaq
- Market Cap
- RNA 4.0B
- GNW 3.5B
- IPO Year
- RNA 2020
- GNW 2004
- Fundamental
- Price
- RNA $70.76
- GNW $8.55
- Analyst Decision
- RNA Buy
- GNW Buy
- Analyst Count
- RNA 20
- GNW 1
- Target Price
- RNA $69.26
- GNW $10.00
- AVG Volume (30 Days)
- RNA 10.1M
- GNW 4.4M
- Earning Date
- RNA 11-10-2025
- GNW 11-05-2025
- Dividend Yield
- RNA N/A
- GNW N/A
- EPS Growth
- RNA N/A
- GNW 160.86
- EPS
- RNA N/A
- GNW 0.52
- Revenue
- RNA $20,868,000.00
- GNW $7,299,000,000.00
- Revenue This Year
- RNA N/A
- GNW N/A
- Revenue Next Year
- RNA $108.97
- GNW N/A
- P/E Ratio
- RNA N/A
- GNW $16.35
- Revenue Growth
- RNA 106.27
- GNW N/A
- 52 Week Low
- RNA $21.51
- GNW $5.99
- 52 Week High
- RNA $70.98
- GNW $9.15
- Technical
- Relative Strength Index (RSI)
- RNA 80.43
- GNW 46.82
- Support Level
- RNA $69.67
- GNW $8.44
- Resistance Level
- RNA $69.86
- GNW $8.75
- Average True Range (ATR)
- RNA 0.47
- GNW 0.20
- MACD
- RNA 0.12
- GNW 0.01
- Stochastic Oscillator
- RNA 94.48
- GNW 37.04
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About GNW Genworth Financial Inc
Genworth Financial Inc is a diversified insurance holding company that provides various mortgage and life insurance products. The company has three main operating business segments: Enact, Life and Annuities segment and Long-Term Care Insurance. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. Majority of the revenue is generated by the Enact segment. The company earns maximum of its revenue in the United States.